Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Debt Ratio (2017 - 2025)

Historic Debt Ratio for United Therapeutics (UTHR) over the last 14 years, with Q1 2025 value amounting to 0.03.

  • United Therapeutics' Debt Ratio fell 7204.16% to 0.03 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.03, marking a year-over-year decrease of 7204.16%. This contributed to the annual value of 0.04 for FY2024, which is 5828.94% down from last year.
  • United Therapeutics' Debt Ratio amounted to 0.03 in Q1 2025, which was down 7204.16% from 0.04 recorded in Q4 2024.
  • United Therapeutics' 5-year Debt Ratio high stood at 0.17 for Q1 2021, and its period low was 0.03 during Q1 2025.
  • For the 5-year period, United Therapeutics' Debt Ratio averaged around 0.12, with its median value being 0.13 (2023).
  • In the last 5 years, United Therapeutics' Debt Ratio tumbled by 1071.95% in 2021 and then tumbled by 7204.16% in 2025.
  • Quarter analysis of 5 years shows United Therapeutics' Debt Ratio stood at 0.15 in 2021, then decreased by 14.48% to 0.13 in 2022, then fell by 26.2% to 0.1 in 2023, then plummeted by 58.29% to 0.04 in 2024, then tumbled by 36.6% to 0.03 in 2025.
  • Its Debt Ratio was 0.03 in Q1 2025, compared to 0.04 in Q4 2024 and 0.06 in Q3 2024.